Mr. Anthony Blacker (Consultant Urological surgeon)

About Mr. Anthony Blacker

• Role: Consultant Urological surgeon
  
• Year of First Medical Qualification: 1992
  
• Location of Medical Training: University of Birmingham
  
• Date Joined University Hospitals Coventry & Warwickshire: 2005
  
• Membership of Professional / National / Regional Bodies:
  British association of urological surgeons (BAUS).
  
• Other Professional Details:
  MBChB, FRCS (Urol)
  
  Research profile which includes publications
  Primary Investigator for the PARTIAL study 2023 looking at the outcomes of different surgery for small kidney tumours.
  Primary Investigator for the PuRE study 2018-20 looking at the surgical management of lower pole renal stones, also for PuRE-Qual looking at barriers to recruitment.
  Primary Investigator for the POUT study 2013-17 looking at adjuvant chemotherapy post nephroureterectomy, and the translational spin off POUT-T study 2014.
  Primary Investigator for the Ethicon surgical stapler study 2016 using a new surgical stapler during laparoscopic nephrectomies, UHCW was usually the highest monthly recruiter globally.
  Co-investigator for the Panther and SORCE studies looking at the use of TKI drugs for patients with kidney cancer.
  Publications:
  Birtle A, Chester J, Jones R, Jenkins B, Johnson M, Catto J, Powles T, Bryan R, Blacker A, Chakraborti P, Jagdev S, Wagstaff J, Tolentino A, Webster L, Lewis R, Hall E. Updated outcomes of POUT: A phase III randomized trial of peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC). Journal of Clinical Oncology. 2021. 39(6)suppl: 455-455
  
  Birtle A, Johnson M, Chester J, Jones R, Dolling D, Bryan R, Harris C, Winterbottom A, Blacker A, Catto J, Chakraborti P, Donovan J, Elliott P, French A, Jagdev S, Jenkins B, Keeley F, Kockelbergh R, Powles T, Wagstaff J, Wilson C, Todd R, Lewis R, Hall E. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. The Lancet 2020; 395(10232): 1268-1277
  
• Special Interests:
  All forms of surgery for surgical kidney problems, specialising in minimally invasive approaches endoscopic, percutaneous, laparoscopic and robotic surgery for kidney tumours and stones. By 2023 of about 250 partial nephrectomies, 100 have been done robotically, with World-class outcomes.
  International work. He has worked and taught on stone and laparoscopic courses in Egypt and Sri Lanka. During training he learnt laparoscopy in both France and Belgium.
  

Contact Information

Secretary: Jane Kendrick
Telephone: 02476 965259
Email: Jane.Kendrick@uhcw.nhs.uk